AAAAAA

   
Results: 1-17 |
Results: 17

Authors: WANG DY FORSLUND C PERSSON U WIHOLM BE
Citation: Dy. Wang et al., DRUG-ATTRIBUTED ANAPHYLAXIS, Pharmacoepidemiology and drug safety, 7(4), 1998, pp. 269-274

Authors: WIHOLM BE SUNDSTROM A ALFREDSSON L
Citation: Be. Wiholm et al., USE OF CALCIUM-CHANNEL BLOCKERS AND RISK OF SUICIDE - DRUG PRESCRIPTIONS OVER LONGER PERIOD SHOULD HAVE BEEN FOLLOWED UP, BMJ. British medical journal, 317(7165), 1998, pp. 1076-1077

Authors: WIHOLM BE KELLY JP KAUFMAN D ISSARAGRISIL S LEVY M ANDERSON T SHAPIRO S
Citation: Be. Wiholm et al., RELATION OF APLASTIC-ANEMIA TO USE OF CHLORAMPHENICOL EYE DROPS IN 2 INTERNATIONAL CASE-CONTROL STUDIES, BMJ. British medical journal, 316(7132), 1998, pp. 666-666

Authors: CAPELLA D LAPORTE JR VIDAL X WIHOLM BE BEGAUD B LANGMAN MJS RAWLINS M
Citation: D. Capella et al., EUROPEAN NETWORK FOR THE CASE-POPULATION SURVEILLANCE OF RARE DISEASES (EURONET) - A PROSPECTIVE FEASIBILITY STUDY, European Journal of Clinical Pharmacology, 53(5), 1998, pp. 299-302

Authors: LASZLO A KELLY JP KAUFMAN DE SHEEHAN JE RETSAGI G WIHOLM BE KOFF RS SUNDSTROM A SHAPIRO S
Citation: A. Laszlo et al., CLINICAL ASPECTS OF UPPER GASTROINTESTINAL-BLEEDING ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS, The American journal of gastroenterology, 93(5), 1998, pp. 721-725

Authors: SPIGSET O HEDENMALM K DAHL ML WIHOLM BE DAHLQVIST R
Citation: O. Spigset et al., SEIZURES AND MYOCLONUS ASSOCIATED WITH ANTIDEPRESSANT TREATMENT - ASSESSMENT OF POTENTIAL RISK-FACTORS, INCLUDING CYP2D6 AND CYP2C19 POLYMORPHISMS, AND TREATMENT WITH CYP2D6 INHIBITORS, Acta psychiatrica Scandinavica, 96(5), 1997, pp. 379-384

Authors: KAUFMAN DW KELLY JP JURGELON JM ANDERSON T ISSARAGRISIL S WIHOLM BE YOUNG NS LEAVERTON P LEVY M SHAPIRO S
Citation: Dw. Kaufman et al., DRUGS IN THE ETIOLOGY OF AGRANULOCYTOSIS AND APLASTIC-ANEMIA, European journal of haematology, 57, 1996, pp. 23-30

Authors: WIHOLM BE EMANUELSSON S
Citation: Be. Wiholm et S. Emanuelsson, DRUG-RELATED BLOOD DYSCRASIAS IN A SWEDISH REPORTING SYSTEM, 1985-1994, European journal of haematology, 57, 1996, pp. 42-46

Authors: EDWARDS IR WIHOLM BE MARTINEZ C
Citation: Ir. Edwards et al., CONCEPTS IN RISK-BENEFIT ASSESSMENT - A SIMPLE MERIT ANALYSIS OF A MEDICINE, Drug safety, 15(1), 1996, pp. 1-7

Authors: STEINECK G WIHOLM BE DEVERDIER MG
Citation: G. Steineck et al., ACETAMINOPHEN, SOME OTHER DRUGS, SOME DISEASES AND THE RISK OF TRANSITIONAL-CELL CARCINOMA - A POPULATION-BASED CASE-CONTROL STUDY, Acta oncologica, 34(6), 1995, pp. 741-748

Authors: KELLY JP KAUFMAN DW KOFF RS LASZLO A WIHOLM BE SHAPIRO S
Citation: Jp. Kelly et al., ALCOHOL-CONSUMPTION AND THE RISK OF MAJOR UPPER GASTROINTESTINAL-BLEEDING, The American journal of gastroenterology, 90(7), 1995, pp. 1058-1064

Authors: LUNDE H HEDNER T SAMUELSSON O LOTVALL J ANDREN L LINDHOLM L WIHOLM BE
Citation: H. Lunde et al., DYSPNEA, ASTHMA, AND BRONCHOSPASM IN RELATION TO TREATMENT WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS, BMJ. British medical journal, 308(6920), 1994, pp. 18-21

Authors: BENGTSSON BO WIHOLM BE MYRHED M WALINDER J
Citation: Bo. Bengtsson et al., ADVERSE EXPERIENCES DURING TREATMENT WITH ZIMELDINE ON SPECIAL LICENSE IN SWEDEN, International clinical psychopharmacology, 9(1), 1994, pp. 55-61

Authors: ROMANUS V FASTH A TORDAI P WIHOLM BE
Citation: V. Romanus et al., ADVERSE REACTIONS IN HEALTHY AND IMMUNOCOMPROMISED CHILDREN UNDER 6 YEARS OF AGE VACCINATED WITH THE DANISH BCG VACCINE, STRAIN COPENHAGEN 1331 - IMPLICATIONS FOR THE VACCINATION POLICY IN SWEDEN, Acta paediatrica, 82(12), 1993, pp. 1043-1052

Authors: WIHOLM BE
Citation: Be. Wiholm, THE CONSEQUENCES OF A DRUG-WITHDRAWAL FROM THE MARKET, Therapie, 48(5), 1993, pp. 433-433

Authors: WIHOLM BE MYRHED M
Citation: Be. Wiholm et M. Myrhed, METFORMIN-ASSOCIATED LACTIC-ACIDOSIS IN SWEDEN 1977-1991, European Journal of Clinical Pharmacology, 44(6), 1993, pp. 589-591

Authors: KAUFMAN DW KELLY JP SHEEHAN JE LASZLO A WIHOLM BE ALFREDSSON L KOFF RS SHAPIRO S
Citation: Dw. Kaufman et al., NONSTEROIDAL ANTIINFLAMMATORY DRUG-USE IN RELATION TO MAJOR UPPER GASTROINTESTINAL-BLEEDING, Clinical pharmacology and therapeutics, 53(4), 1993, pp. 485-494
Risultati: 1-17 |